Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.69 |
| ▸ | TK1 | P04183 | 6/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | ALB | P02768 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523267 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL523268 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL16359947 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL19132672 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL12670320 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL25756080 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL8996152 | 0.91 | RNASE1 (0.70) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL22992460 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL4286458 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL27989242 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0391411-A2 | 3'-Substituted methyl nucleosides as antiviral agents | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | claimed |
| EP-0391411-A2 | 3'-Substituted methyl nucleosides as antiviral agents | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | disclosed |